Clinical trial
Transplantation of Umbilical Cord Blood in Patients With Hematological Malignancies Using a Reduced-Intensity Preparative Regimen (A Multi-Center Trial Coordinated by the FHCRC)
NCT00723099 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transplantation of Umbilical Cord Blood in Patients With Hematological Malignancies Using a Reduced-Intensity Preparative Regimen (A Multi-Center Trial Coordinated by the FHCRC)
- Lead sponsor
- Fred Hutchinson Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 25, 2008
- Completion date
- July 31, 2018
- Enrollment
- 73 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, acute myeloid leukemia, aggressive non-hodgkin lymphoma, chronic myelogenous leukemia, chronic phase chronic myelogenous leukemia, indolent non-hodgkin lymphoma, lymphoma, mixed phenotype acute leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, recurrent chronic lymphocytic leukemia, recurrent follicular lymphoma, recurrent lymphoplasmacytic lymphoma, recurrent mantle cell lymphoma, recurrent marginal zone lymphoma, recurrent plasma cell myeloma, recurrent small lymphocytic lymphoma, recurrent t-cell non-hodgkin lymphoma, refractory chronic lymphocytic leukemia, refractory chronic myelogenous leukemia, refractory follicular lymphoma, refractory hodgkin lymphoma, refractory lymphoplasmacytic lymphoma, refractory mantle cell lymphoma, refractory small lymphocytic lymphoma, t-cell non-hodgkin lymphoma